ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,597.95
-0.44%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Pfizer Inc (PFE)

  7. Pfizer Inc (PFE) News

Pfizer (PFE)

Pfizer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:PFE
DateTimeSourceHeadlineSymbolCompany
20/11/202411:45Business WirePfizer Announces New Chief Scientific Officer and President, Research & DevelopmentNYSE:PFEPfizer Inc
20/11/202409:00Business WireEuropean Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without InhibitorsNYSE:PFEPfizer Inc
18/11/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
18/11/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
14/11/202415:00Business WirePfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare ConferenceNYSE:PFEPfizer Inc
04/11/202415:00Business WirePfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare ConferenceNYSE:PFEPfizer Inc
01/11/202419:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
01/11/202419:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
31/10/202420:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
29/10/202413:09IH Market NewsFutures Pointing To Modestly Lower Open On Wall StreetNYSE:PFEPfizer Inc
29/10/202412:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:PFEPfizer Inc
29/10/202410:45Business WirePfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 GuidanceNYSE:PFEPfizer Inc
29/10/202409:41IH Market NewsUS Futures Rise as Investors Await Major Earnings; Oil Prices Rebound with US Reserve Refill PlanNYSE:PFEPfizer Inc
28/10/202413:09IH Market NewsSteep Drop By Oil Prices May Lead To Initial Strength On Wall StreetNYSE:PFEPfizer Inc
23/10/202420:45Business WireAdvisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and OlderNYSE:PFEPfizer Inc
22/10/202420:45Business WireU.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for DiseaseNYSE:PFEPfizer Inc
16/10/202420:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/10/202420:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
15/10/202421:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
15/10/202421:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:PFEPfizer Inc
15/10/202411:18Edgar (US Regulatory)Form 8-K - Current reportNYSE:PFEPfizer Inc
15/10/202410:45Business WireTim Buckley Elected to Pfizer’s Board of DirectorsNYSE:PFEPfizer Inc
14/10/202410:11IH Market NewsTSMC To Exceed Profits, Plans European Factories; Boeing Cuts 17,000 Jobs; Berkshire Boosts Sirius XM StakeNYSE:PFEPfizer Inc
11/10/202418:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
11/10/202418:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
11/10/202417:23Business WireU.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without InhibitorsNYSE:PFEPfizer Inc
11/10/202410:31IH Market NewsBP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO Announces Retirement; Berkshire Trims BofA Stake, and MoreNYSE:PFEPfizer Inc
10/10/202410:51Business WirePfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 TrialNYSE:PFEPfizer Inc
10/10/202410:45IH Market NewsTesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits; 10x Genomics Stock Drops on Revenue ForecastNYSE:PFEPfizer Inc
09/10/202420:30Business WirePfizer Declares Fourth-Quarter 2024 DividendNYSE:PFEPfizer Inc
 Showing the most relevant articles for your search:NYSE:PFE

Your Recent History

LSE
BARC
Barclays
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06